A case of levocetirizine-induced liver injury

3Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Levocetirizine is a second-generation nonsedative antihistaminic agent that has been demonstrated to be safe and effective for treating allergic disease. There was only one case report of levocetirizine-induced liver toxicity, but a liver biopsy was not performed. In this article, we present the first case of levocetirizine-induced liver injury with histologic findings. A 48-year-old man was hospitalized with jaundice and generalized pruritus that had developed after 2 months of therapy with levocetirizine for prurigo nodularis. Laboratory findings revealed acute hepatitis with cholestasis. A liver biopsy demonstrated portal inflammation and hepatitis with apoptotic hepatocytes. The patient fully recovered 3 weeks after withdrawing levocetirizine. Although levocetirizine is safe and effective, physicians should be aware of its potential hepatotoxicity.

Cite

CITATION STYLE

APA

Jung, M. C., Kim, J. K., Cho, J. Y., Song, J. W., Lee, B., Park, J. W., … Kim, S. E. (2016). A case of levocetirizine-induced liver injury. Clinical and Molecular Hepatology, 22(4), 495–498. https://doi.org/10.3350/cmh.2016.0023

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free